China National Medicines Corporation Ltd. (SHA: 600511)

China National Medicines Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,616	10,926	8,896	7,304	6,225	5,702
Trading Asset Securities	-	-	-	11.4	-	-
Cash & Short-Term Investments	8,616	10,926	8,896	7,316	6,225	5,702
Cash Growth	10.28%	22.81%	21.60%	17.53%	9.16%	11.83%
Accounts Receivable	15,106	12,881	12,550	13,392	12,507	12,075
Other Receivables	192.33	204	389.69	79.93	129.77	221.49
Receivables	15,298	13,085	12,940	13,472	12,637	12,297
Inventory	4,961	3,961	3,717	3,515	3,050	3,356
Other Current Assets	308.31	307.79	210.44	280.62	198.65	320.83
Total Current Assets	29,184	28,279	25,764	24,584	22,110	21,676
Property, Plant & Equipment	907.22	827.04	857.91	845.06	895.73	832.74
Long-Term Investments	1,928	1,907	1,623	1,365	1,141	933.49
Goodwill	203.77	203.77	203.77	203.77	203.77	203.77
Other Intangible Assets	264.66	258.11	262.92	258.65	256.12	263.78
Long-Term Deferred Tax Assets	137.99	123.87	124.37	115.94	100.6	106.99
Long-Term Deferred Charges	156.11	150.06	86.19	89.6	90.31	71.81
Other Long-Term Assets	772.51	703.57	686.95	548.08	108.13	105.06
Total Assets	33,554	32,453	29,609	28,010	24,905	24,194
Accounts Payable	11,923	10,943	9,917	10,058	8,990	9,404
Accrued Expenses	369.98	604.96	640.01	564.03	514.43	611.46
Short-Term Debt	239.71	268.35	252.06	428.83	471.83	348.92
Current Portion of Leases	96.34	74.08	80.5	75.81	70.12	42.21
Current Income Taxes Payable	48.26	113.17	84.89	112.18	76.99	107.59
Current Unearned Revenue	105.95	61.12	176.9	43.68	66.59	68.3
Other Current Liabilities	1,578	1,830	1,589	1,457	1,047	1,021
Total Current Liabilities	14,361	13,894	12,740	12,739	11,237	11,603
Long-Term Leases	281.17	205.08	182.57	197.29	260.09	166.62
Long-Term Unearned Revenue	42.42	46.06	46.35	42.66	45.53	39.54
Long-Term Deferred Tax Liabilities	27.54	26.78	33.47	35.39	40.84	46.43
Other Long-Term Liabilities	899.32	747.14	747.14	639.8	226.62	178.07
Total Liabilities	15,612	14,920	13,750	13,655	11,811	12,035
Common Stock	754.5	754.5	754.5	754.5	754.5	754.5
Additional Paid-In Capital	2,349	2,349	2,349	2,349	2,349	2,349
Retained Earnings	12,998	12,642	11,087	9,652	8,312	7,411
Comprensive Income & Other	22.21	30.74	24.04	24.91	27.69	22.45
Total Common Equity	16,123	15,776	14,215	12,780	11,444	10,537
Minority Interest	1,818	1,757	1,645	1,575	1,650	1,622
Shareholders' Equity	17,942	17,533	15,859	14,355	13,094	12,159
Total Liabilities & Equity	33,554	32,453	29,609	28,010	24,905	24,194
Total Debt	617.22	547.5	515.13	701.93	802.04	557.75
Net Cash (Debt)	7,999	10,378	8,381	6,614	5,423	5,144
Net Cash Growth	8.64%	23.83%	26.72%	21.97%	5.41%	26.29%
Net Cash Per Share	10.60	13.76	11.11	8.77	7.19	6.75
Filing Date Shares Outstanding	754.5	754.5	754.5	754.5	754.5	754.5
Total Common Shares Outstanding	754.5	754.5	754.5	754.5	754.5	754.5
Working Capital	14,823	14,385	13,025	11,845	10,872	10,073
Book Value Per Share	21.37	20.91	18.84	16.94	15.17	13.97
Tangible Book Value	15,655	15,314	13,748	12,318	10,984	10,070
Tangible Book Value Per Share	20.75	20.30	18.22	16.33	14.56	13.35
Buildings	408.84	408.84	433.49	387.18	381.37	388.93
Machinery	773.47	759.8	702.78	661.15	629.64	616.3
Construction In Progress	0.84	2.54	36.21	57.09	13.24	12.12

Source: S&P Capital IQ. Standard template. Financial Sources.